- Staat
- TN
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 17.11.2023
- Impfdatum
- 17.11.2023
- Beginn
- 17.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Nausea
Symptomtext
Within approximately 2 minutes of receiving the vaccine, patient passed out. He was given an ice pack and responded to gentle stimuli within 1-2 minutes. Patient then verbalized he felt like he might vomit, mom reports he did not eat breakfast this morning. He was given crackers and a sprite and was monitored for an additional 20 minutes. Patient fully recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 10.02.2023
- Impfdatum
- 09.02.2023
- Beginn
- 09.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Supine position
Syncope
Symptomtext
Upon administration of Kinrix in left deltoid, patient experienced a syncopal episode. This was the fourth and final vaccine administered at this visit. Patient collapsed backwards onto exam table. Dr. was called in to examine. Dr. determined this to be a syncopal episode. Patient was not postictal and was not presenting with signs of anaphylactic reaction. Pt was alert and conscious after approximately 30 seconds from time of syncopal episode. Patient reported experiencing dizziness and light-headedness. Patient was positioned supine for 30 minutes. Patient drank juice box and reported resolution of symptoms. Patient was monitored for a total of 40 minutes from time of episode. Patient was able to ambulate normally and went home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- No history of syncopal episodes per mother.
- Aktuelle Erkrankungen
- None documented
- Vorgeschichte
- Intermittent Explosive Disorder
- Andere Medikamente
- Vitamin C, Multivitamin, Probiotic
- Allergien
- None documented
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.11.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Gait disturbance
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
10/18/23 (1 day post vaccine) Significant swelling, warmth, tenderness to anterior Right thigh associated with limp/difficulty ambulation onset <24hrs after vaccine administration thigh circumference R 1 inch < Left Patient returned for f/u 10/23/23 6 days post vaccine with complete resolution of symptoms
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 06.10.2023
- Impfdatum
- 20.09.2023
- Beginn
- 23.09.2023
- Tage bis Beginn
- 3,0
- Dosis
- 5
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Drainage
Injection site rash
Loss of personal independence in daily activities
Pyrexia
Rash
Rash pruritic
Respiratory rate increased
Scratch
Symptomtext
recvd vaccine Wed, Sunday mom noticed rash at injection site which spread to generalized body area, becoming itchy with clear drainage from some of the sites where pt had scratched. Tactile fever present on Tuesday 9/26. Pt was sent home from school on Thursday 9/28 due to rash presented to ED with c/o increased respiratory rate overnight that resolved and continued rash. ED determined vaccine induced varicella.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site rash
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- Hemihypertrophy
- Andere Medikamente
- n/A
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 29.09.2023
- Impfdatum
- 28.02.2019
- Beginn
- 28.09.2023
- Tage bis Beginn
- 1.673,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Injection site erythema
Injection site swelling
Injection site warmth
Symptomtext
Child's leg at injection site became red, warm and swollen the next day. Second day after injection redness spread. Mother had applied cool compress. Took to ER when worsened
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 28.07.2023
- Impfdatum
- 24.07.2023
- Beginn
- 25.07.2023
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Injection site warmth
Symptomtext
EXTENSIVE AREA OF REDNESS, WARMTH AND SWELLING, NON TENDER ,COVERING THE LATERAL ASPECT OF THE LEFT THIGH
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- REACTIVE AIRWAY DISEASE
- Andere Medikamente
- NONE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 13.07.2023
- Impfdatum
- 11.07.2023
- Beginn
- 12.07.2023
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pruritus
Injection site swelling
Symptomtext
Redness and swelling at the injection site with itchiness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 19.05.2023
- Impfdatum
- 16.05.2023
- Beginn
- 18.05.2023
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site reaction
Injection site warmth
Urticaria
Symptomtext
4 inches by 3 inches urticial rash at injection site. Warm to touch
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 03.05.2023
- Impfdatum
- 25.04.2023
- Beginn
- 27.04.2023
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site cellulitis
Symptomtext
cellulitis at injection site
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site cellulitis
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 02.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 29.04.2023
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Contusion
Erythema
Injection site pruritus
Injection site rash
Skin lesion
Skin warm
Swelling
Symptomtext
4/28/23 rash noted at R thigh injection site 4/29/23 pt. c/o itching at R thigh site but area appeared normal 4/30/23 pt. awoke with quarter sized lesion that increased in size over 6 hours to a large 3-4 inch circle area. Hot to touch, red and swollen. 5/1/23 Area became enlarged outside the marked circle 5/2/23 Bruising along with the redness, heat and swelling
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- evaluated by MD 5-2-23, antibiotic prescribed
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 01.05.2023
- Impfdatum
- 26.04.2023
- Beginn
- 27.04.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Immunisation reaction
Injection site erythema
Injection site mass
Symptomtext
Patient mother noticed small nickel size lump on the Left thighs on 4-27-23. Mother denies giving any OTC medication at the time. Mother states child continued to play as normal. Next day on the 4-28-2023 mother saw lump was now red and larger. Mother then called clinic to notify us of the possible reaction. Mother was brought in to the clinic for further evaluation. PCP did confirm reaction to Kinrix. child was administered 10 ml of Benadryl in Clinic. Mother was sent home with child to further monitor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Diarrhea
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 06.04.2023
- Impfdatum
- 03.04.2023
- Beginn
- 04.04.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Adverse reaction
Injection site erythema
Injection site swelling
Injection site warmth
Symptomtext
Mother called clinic to notify us of swelling and redness to the left thigh. Mother states child woke on 4-4-23 with redness and swelling to the left thigh. Mother gave 24 hours of watching for any improvement. mother called on 4-5-2023 at 8 Am to notify us of the swelling, redness and warm to the touch. Denied any SOB, raspatory distress mother was advised to head to the clinic and have child evaluated for symptoms. Provider confirmed adverse reaction to the site. child had 3 x 3 1/2 of redness and swelling on the LT thigh. child was advised to give a dose of Benadryl and notify clinic of any extreme changes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 24.02.2023
- Impfdatum
- 21.02.2023
- Beginn
- 23.02.2023
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Erythema
Peripheral swelling
Pruritus
Rash erythematous
Skin discolouration
Streptococcus test negative
Urticaria
Symptomtext
Called MD on call. Swelling & hives hands & arms bil. Were starting to look purple. Face & body five red bumps, itchy feet bright red. Took Allegra & went to ER. as advised
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- 2/21/23 Strep test Neg. 2/23/23 Strep test Neg
- Aktuelle Erkrankungen
- Tonsillitis Negative Strep
- Vorgeschichte
- -
- Andere Medikamente
- Sodium Flurid 05 ml daily
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 21.02.2023
- Impfdatum
- 15.02.2023
- Beginn
- 15.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Urticaria
Symptomtext
Pt developed hives and rash on forehead. 1 dose of oral Benadryl was given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Viral URI
- Vorgeschichte
- Mild intermittent Asthma
- Andere Medikamente
- unknown
- Allergien
- NKA, NKMA
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 19.01.2023
- Impfdatum
- 19.01.2023
- Beginn
- 19.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Emotional distress
Erythema
Immediate post-injection reaction
Incorrect route of product administration
Injection site erythema
Injection site urticaria
Injection site warmth
Patient uncooperative
Underdose
Symptomtext
Rec injection lt deltiod and child suddenly threw arm upward near the end, there was y a very tiny amount of vaccine left in syringe, As the syring was moving to come out tiny amount appeared to have been injected into the subcut area, small wheel developed with redness and warmth to the lt deltoid area immediately. Reddness extended downward of arm and small amount across back of shoulder blade. Child extremely upset and guardian indicated when child gets upset will redden with flushed face and upper extremities. No rash noted on trunk or back region, no facial swelling or rash to face, tongue with no swelling, airway patient, no hoarseness noted, child with easy work of breathing without wheezes noted. child easily consoled per guardian. Observed for approx 10 minutes in exam, no change in condition, Medical director notified of situation,, status update given and inform parent to monitor closely at home. Condition of extremity improved prior to leaving clinic. Parent contated later in afternoon, child active and playing , child wanting to go to school, parent reports redness and small wheel presentation almost completely resolved. Spoke with MD again, recommendation discussed with parent for repeat dose and follow up with Pediatrician within 24-48 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 18.01.2023
- Impfdatum
- 12.01.2023
- Beginn
- 14.01.2023
- Tage bis Beginn
- 2,0
- Dosis
- 5
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Injection site discolouration
Skin warm
Symptomtext
Guardian reports patient experience redness and warmth to area 48 hours post injection. Guardian reports patient was given Benadryl in case of allergic reaction to medication. Patient noted to have discoloration approximately 2 and one half cm around injection site. Patient denies any discomfort at time of visit today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site discolouration
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- Anemia
- Vorgeschichte
- none
- Andere Medikamente
- None
- Allergien
- No Known Allergies
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 12.01.2023
- Impfdatum
- 10.01.2023
- Beginn
- 10.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site pruritus
Injection site swelling
Symptomtext
Softball-sized red area to left upper thigh. Itchy, swollen, tender.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/a
- Vorgeschichte
- N/a
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 04.01.2023
- Impfdatum
- 19.12.2022
- Beginn
- 19.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Pruritus
Pyrexia
Streptococcus test
Tympanic membrane disorder
Tympanic membrane hyperaemia
Urticaria
Symptomtext
Pt's parent reports fever and hives all over body following vaccination. Uticarial rash lasting 2-3 days On 12/21 Phone consult with Our clinic provider. Assessed for uticarial rash x 2 day. given Benadryl to reduce itchiness/Hives. Pt went to ER for fever and was found to have bulging and erythema on L tympanic membrane on 12/22. - Given APAP and Amoxicillin.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- On 12/21 Phone consult with Our clinic provider. Assessed for uticarial rash x 2 day. given Benadryl to reduce itchiness/Hives. ER prec for ongoing fever. Pt went to ER for fever and was found to have bulging and erythema on L tympanic membrane on 12/22. Strep testing 12/22; COVID and Flu testing on 12/16.
- Aktuelle Erkrankungen
- Mild cold at time of vaccine, NEg for flu and COVID. . COVID Feb/2021
- Vorgeschichte
- Born with VSD, Small perimembranous VSD 2. Normal biventricular septum
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 14.12.2022
- Impfdatum
- 08.11.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 23,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Ear pain
Ear swelling
Parotitis
Rubulavirus test positive
Swelling
Swelling face
Symptomtext
Office visit 12/01/2022 - Left side of face, neck and ear swollen and painful x1 day. Recommended being seen at ER. Was seen at ED for left facial swelling. Dx'd with parotitis. Treated with IV abx, as well as well as amox. Symptoms have resolved. Back to normal self. Follow up office visit on 12/08/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ear pain
- Hospital-Tage
- -
- Labordaten
- Mumps IGM was positive during ER visit.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 09.12.2022
- Impfdatum
- 07.12.2022
- Beginn
- 08.12.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Headache
Pain in extremity
Pyrexia
Vomiting
Symptomtext
Patient developed fever, arm pain, vomiting, headache, and abdominal pain the morning after vaccination. Improved after 24 hours. Symptomatic care only. Has sick contacts currently with gastroenteritis symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 24.10.2022
- Impfdatum
- 20.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Symptomtext
Left thigh with minimal erythema and swelling starting 10/21/22 at or around 3:30pm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- Milk and Soy
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 22.11.2023
- Impfdatum
- 12.01.2023
- Beginn
- 12.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
received a extra dose 12-JAN-2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 5-year-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M) for prophylaxis. Previously administered products included Kinrix (On 10th February 2022, received dose). Additional patient notes included the patient was asymptomatic.. On 12-JAN-2023, the patient received Kinrix. On 12-JAN-2023, an unknown time after receiving Kinrix, the patient experienced extra dose administered (Verbatim: received a extra dose 12-JAN-2023). The outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 13-NOV-2023 The reporter reported that the patient received extra dose of Kinrix, which led to extra dose administered. The patient was asymptomatic. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: the patient was asymptomatic.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- -
- Geschlecht
- M
- Eingang
- 20.11.2023
- Impfdatum
- 01.11.2023
- Beginn
- 01.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
patient was due for Pediarix but got Kinrix instead; a patient who is 5 months old inadvertently received a dose of Kinrix; a patient who is 5 months old inadvertently received a dose of Kinrix/Kinrix was the patient's 2nd DTaP and 2nd Polio; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 5-month-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On 01-NOV-2023, the patient received Kinrix. On 01-NOV-2023, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: patient was due for Pediarix but got Kinrix instead), inappropriate age at vaccine administration (Verbatim: a patient who is 5 months old inadvertently received a dose of Kinrix) and inappropriate schedule of vaccine administered (Verbatim: a patient who is 5 months old inadvertently received a dose of Kinrix/Kinrix was the patient's 2nd DTaP and 2nd Polio). The outcome of the wrong vaccine administered, inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-NOV-2023 The nurse reported that a patient who was 5 months old inadvertently received a dose of Kinrix, which led to inappropriate age at vaccine administration. The patient was due for Pediarix but got Kinrix instead, which led to wrong vaccine administered. The Kinrix was the patient's 2nd DTaP and 2nd Polio dose, which led to inappropriate schedule of vaccine administered. The reporter stated, had they received Pediarix, it would have been the patients 3rd dose of Hepatitis B. The reporter consented to follow up via email.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 15.11.2023
- Impfdatum
- 15.11.2023
- Beginn
- 15.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
KINRIX- LOT # 2KL4K- EXPIRED 11/9/23. PT DID NOT DISPLAY ANY SIGNS OR SYMPTOMS OF DISTRESS AFTER RECEIVING THE VACCINATION. PT WAS RE-VACCINATED WITH KINRIX PER GUIDELINES DURING SAME OFFICE VISIT.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 1,7
- Geschlecht
- M
- Eingang
- 15.11.2023
- Impfdatum
- 15.11.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No adverse reactions noted. Client was administered Kinrix( Dtap and IPV) combination vaccine. Vaers report is being made due to the client's age at time of vacciation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- fifth disease last week.
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- soy
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 1,7
- Geschlecht
- M
- Eingang
- 10.11.2023
- Impfdatum
- 08.11.2023
- Beginn
- 08.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Writer received notification that patient incorrectly received Kinrix (DTaP/IPV) vaccination instead of age appropriate separate DTaP, IPV vaccination based on parent preference.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 10.11.2023
- Impfdatum
- 10.02.2022
- Beginn
- 12.01.2023
- Tage bis Beginn
- 336,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
Extra dose of kinrix administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 01.11.2023
- Impfdatum
- 01.11.2023
- Beginn
- 01.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient was given this vaccine ( Kinrix and MMRV) 9/7/2023. Was not recorded in system, therefore when mom brought in patient for vaccinations today, the system report states that she needed this vaccine, when in fact she did not. Our Electronic health record did not cross over information to the data base from the 9/7/2023 visit. When I sat down to enter the data in our EHR, I noted that these vaccines were duplicated today. These vaccines were given again today as well as the influenza vaccine. So double doses of the Kinrix and MMRV Proquad were given in a1 month and 24 days time frame. MD was notified as well as our clinic. Mother was also notified after the incident as well. Patient received a influenza vaccine as well today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none listed
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 28.10.2023
- Impfdatum
- 16.10.2023
- Beginn
- 16.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
inadvertently administered Kinrix; inadvertently administered Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-year-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2023) for prophylaxis. On 16-OCT-2023, the patient received Kinrix. On 16-OCT-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: inadvertently administered Kinrix) and inappropriate schedule of vaccine administered (Verbatim: inadvertently administered Kinrix). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date 18 Oct 2023 Medical Assistant called to inquire, what to look for? How to proceed? Medical assistant reported they inadvertently administered Kinrix to sibling patients. MA mentioned both patients needed both DTAP and IPV and Kinrix had both but noticed the recommended age after. The HCP stated, it was the 3rd dose of DTAP and 3rd dose of IPV for each patient. The reporter did not consent to follow-up. 2 year patient received kinrix, as 3rd dose of DTAP and 3rd dose of IPV which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. This case has been linked with case reported by same reporter.; Sender's Comments: US-GSK-US2023144288:Same reporter,2nd patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 28.10.2023
- Impfdatum
- 16.10.2023
- Beginn
- 16.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
Inadvertently administered Kinrix to sibling patients/but noticed the recommended age after; 3rd dose of DTAP and 3rd dose of IPV; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On 16-OCT-2023, the patient received Kinrix. On 16-OCT-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Inadvertently administered Kinrix to sibling patients/but noticed the recommended age after) and inappropriate schedule of vaccine administered (Verbatim: 3rd dose of DTAP and 3rd dose of IPV). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-OCT-2023 The reporter was a medical assistant. The reporter reported that they inadvertently administered Kinrix vaccine to patient. The reporter mentioned that patient need to receive both DTAP and IPV and Kinrix had both but noticed the recommended age. The reporter stated that it was the 3rd dose of DTAP and 3rd dose of IPV for the patient. The patient received Kinirix who was younger than the indicated age which led to inappropriate age at vaccine administration. This US2023144287 case has been linked to the case reported by the same reporter. The reporter did not consent to follow up.; Sender's Comments: US-GSK-US2023144287:Same reporter,2nd patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 16.10.2023
- Impfdatum
- 16.10.2023
- Beginn
- 16.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient was given dtap/IPV immunization. Patient is was not in the correct age frame for that immunization to be given. ages for vaccine are 4-6 years of age. Patient's guardian was notified before she left. Patient did not show any adverse reaction to the vaccine. Provider was notified of this, she checked CDC guideline for adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 16.10.2023
- Impfdatum
- 16.10.2023
- Beginn
- 16.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Symptomtext
No side effects reported at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- None
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 1,7
- Geschlecht
- F
- Eingang
- 16.10.2023
- Impfdatum
- 25.05.2023
- Beginn
- 01.05.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
The patient was administered Kinrix vaccine. No adverse reactions to the vaccine noted. The dose is valid per system.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 18.09.2023
- Impfdatum
- 18.09.2023
- Beginn
- 18.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- 7+
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
Adult patient received Kinrix instead of Boostrix. Patient aware, no adverse effects noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 08.09.2023
- Impfdatum
- 06.09.2023
- Beginn
- 07.09.2023
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Swelling
Symptomtext
REDNESS AND SWELLING
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 11.08.2023
- Impfdatum
- 09.08.2023
- Beginn
- 09.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Kinrix was administered to a 9-weeks-old patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 9-week-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On 09-AUG-2023, the patient received Kinrix. On 09-AUG-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix was administered to a 9-weeks-old patient). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 09-AUG-2023 The reporter called to report that the Kinrix was administered to infant patient. The reporter did consent to follow up. The reporter reported that the infant patient administered Kinrix, which leads to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 11.08.2023
- Impfdatum
- 31.07.2023
- Beginn
- 31.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
administered a dose of Kinrix to a 3 year old patient; fourth DTaP dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. Previously administered products included Pediarix (received 1st dose on 27 July 2020), Pediarix (received 2nd dose on 22 September 2020) and Pediarix (received 3rd dose on 24 November 2020). On 31-JUL-2023, the patient received the 4th dose of Kinrix. On 31-JUL-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: administered a dose of Kinrix to a 3 year old patient) and inappropriate schedule of vaccine administered (Verbatim: fourth DTaP dose). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-AUG-2023 Supervisor reported that a nurse at their clinic administered a dose of Kinrix to a patient. The patient had previously had three Pediarix doses (27 July 2020, 22 September 2020, and 24 November 2020), so this was their fourth IPV and DTaP dose. The vaccine administration facility was the same as primary reporter. A 3 year old patient received Kinrix, which led to inappropriate age at vaccine administration. The patient received Kinrix as a 4th dose of DTaP dose, which led to inappropriate schedule of vaccine administered of DTaP. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,5
- Geschlecht
- F
- Eingang
- 11.08.2023
- Impfdatum
- 08.08.2023
- Beginn
- 08.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient received combination vaccine, Kinrix (DTaP-IPV), at the age of 18 months old. Kinrix is licensed to be given to children between the ages of 4 ? 6yrs of age. No adverse reaction/event reported by patient/guardian at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- shellfish
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 04.08.2023
- Impfdatum
- 17.07.2023
- Beginn
- 25.07.2023
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
CSF protein increased
CSF test
General physical health deterioration
Immunoglobulin therapy
Magnetic resonance imaging
Magnetic resonance imaging head abnormal
Magnetic resonance imaging spinal
Muscular weakness
White matter lesion
Symptomtext
acute progressive lower extremity weakness, beginning on 7/25. Worsened and seen in a different ED, on 7/30. Observed overnight and family felt patient was better. DCd on 7/31, but progressively got worse. Seen again on ED 8/2 and transferred to our care for inpatient visit. Patient is on day 3/5 IVIG treatment today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- CSF protein increased
- Hospital-Tage
- -
- Labordaten
- MRI lumbar spine: enhancement of ventral cauda equina nerve roots MRI brain: a few tiny nonspecific FLAIR hyperintense foci present within supratentorial white matter CSF protein elevated (125mg/dL), otherwise negative
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- DC
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 21.07.2023
- Impfdatum
- 14.07.2023
- Beginn
- 14.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
The provider ordered Dtap, IPV, Hib, Hep B and MMRV but did not specify what brand (combination) to give. The medical assistant confirmed the order and asked if Kinirix (Dtap-IPV) could be used. The provider confirmed the use of Kinirix. The MA gave the vaccine. The MA reported the error on 7/14/23 and the case was reviewed by the lead physician with the provider and MA. Corrective action was taken to ensure the provider writes/documents the specific brand of vaccine or combination of vaccine to be given when writing vaccine orders. The MA was re-educated on the requirement not proceed with any order that is not written with the brand or combination identified, to follow the manufacturer instruction and limitations on age printed on the vaccine box and to contact the lead doctor if she has any question about a vaccine. The patient's mother was notified of the error on 7/17/23. The mother has not reported the patient having any symptoms or signs of any consequence from the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None
- Andere Medikamente
- None reported
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 20.07.2023
- Impfdatum
- 01.04.2023
- Beginn
- 26.04.2023
- Tage bis Beginn
- 25,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 18.07.2023
- Impfdatum
- 17.04.2023
- Beginn
- 17.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
A 2 year old was given a Kinrix (DTaP-IPV) which is only for ages 4 years - 6 years.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 14.07.2023
- Impfdatum
- 11.07.2023
- Beginn
- 11.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
No adverse event
Symptomtext
There were no adverse events/outcomes. A early dose of Polio was given too soon. Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) was given to the patient instead of the suggested immunization Infanrix. No reported adverse effects
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- Not applicable
- Aktuelle Erkrankungen
- No known illnesses
- Vorgeschichte
- Genu,Varum
- Andere Medikamente
- Cetirizine 3mL
- Allergien
- seasonal allergies-pollen no known drug allergies
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 27.06.2023
- Impfdatum
- 05.06.2023
- Beginn
- 05.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Kinrix - Inappropriate age; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-month-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On 05-JUN-2023, the patient received Kinrix. On 05-JUN-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix - Inappropriate age). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-JUN-2023 The reporter asked for recommendations on this situation. The reporter consented to follow up via email. The reporter reported that the administration of Kinrix to a 12 month-old patient, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 20.06.2023
- Impfdatum
- 16.06.2023
- Beginn
- 01.06.2023
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
The patient was given Varicella in error
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 13.06.2023
- Impfdatum
- 17.04.2023
- Beginn
- 17.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Kinrix given outside age range
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 0,4
- Geschlecht
- M
- Eingang
- 13.06.2023
- Impfdatum
- 13.03.2023
- Beginn
- 13.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Kinrix given outside age range
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 13.06.2023
- Impfdatum
- 27.01.2023
- Beginn
- 01.01.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Kinrix given outside age range
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 12.06.2023
- Impfdatum
- 01.06.2023
- Beginn
- 01.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Symptomtext
There was no adverse event or outcome with patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 07.06.2023
- Impfdatum
- 06.06.2023
- Beginn
- 01.06.2023
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
MA accidentally administered two doses of Kinrix due to Twin B was present for the same vaccines. The provider spoke to mom and reassured her they should not be any concerns with additional KINRIX dose. Mom expressed understanding.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NDKA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 31.05.2023
- Impfdatum
- 24.05.2023
- Beginn
- 26.05.2023
- Tage bis Beginn
- 2,0
- Dosis
- 5
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Peripheral swelling
Symptomtext
redness and swelling from shoulder to elbow
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ventricular septal defect
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 13.05.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Kinrix administered to a 4mo; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On an unknown date, the patient received Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix administered to a 4mo). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-MAY-2023 The nurse reported that the 4 months old patient had received a doses of kinrix, who was 9 months old at the time of reporting and the nurse mentioned that the vaccine was administered 5 months . The health care professional asked about the effectiveness of the dose. The 4 months old patient received the dose of kinrix which lead inappropriate age of vaccine administered. The permission for follow up was not requested during the call.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 04.05.2023
- Impfdatum
- 01.05.2023
- Beginn
- 01.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Wrong product administered
Symptomtext
Got Kinrix instead of Daptacel; Kinrix was dose #4 of DTaP and IPV; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 6-year-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On 01-MAY-2023, the patient received Kinrix. On 01-MAY-2023, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: Got Kinrix instead of Daptacel) and inappropriate schedule of vaccine administered (Verbatim: Kinrix was dose #4 of DTaP and IPV). The outcome of the wrong vaccine administered and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 01-MAY-2023 The medical assistant reported that a patient received a dose of Kinrix instead of Daptacel inadvertently. This was dose 4 of DTaP and IPV. The reporter consented to follow up via email. The patient received Kinrix (4th dose) instead of Daptacel, which led to wrong vaccine administered and inappropriate schedule of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 0,9
- Geschlecht
- M
- Eingang
- 03.05.2023
- Impfdatum
- 22.04.2023
- Beginn
- 22.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
11 MO received Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-month-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On 22-APR-2023, the patient received Kinrix. On 22-APR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 11 MO received Kinrix). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 24-APR-2023 The health care professional (HCP) reported that an 11 month old received the Kinrix as the 3rd vaccination in the Dtap/IPV series. No reactions reported. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up via email. The patient received Kinrix at inappropriate age, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 8,0
- Geschlecht
- M
- Eingang
- 03.05.2023
- Impfdatum
- 05.04.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
no adverse reactions or symptoms from injection. Immunization of Kinrix given to patient 8years of age. We were instructed by the Health Department to report this as the vaccine is only for ages 4-6yrs of age and patient was out of the age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 28.04.2023
- Impfdatum
- 19.04.2023
- Beginn
- 19.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
21 month old received Kinrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 21-month-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On 19-APR-2023, the patient received Kinrix. On 19-APR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 21 month old received Kinrix). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 20-APR-2023 The nurse reported inadvertent administration of Kinrix to a 21 month old child. The vaccine administration facility was the same as primary reporter. The date of outcome listed as 20th April 2023 was date first reported to GSK. No additional adverse event details were available at that time per reporter. The reporter consented to follow up. The 21 month old patient received Kinrix, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 28.04.2023
- Impfdatum
- 06.04.2023
- Beginn
- 06.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 3,0
- Geschlecht
- M
- Eingang
- 25.04.2023
- Impfdatum
- 29.03.2023
- Beginn
- 29.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
3 year old received Kinrix; Kinrix as 2nd dose of DTaP and IPV; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. Previously administered products included Pediarix (1st dose received on an unknown date). On 29-MAR-2023, the patient received Kinrix. On 29-MAR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 3 year old received Kinrix) and inappropriate schedule of vaccine administered (Verbatim: Kinrix as 2nd dose of DTaP and IPV). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-APR-2023 The nurse reported that a patient received a dose of Kinrix. The reporter clarified regarding the Kinrix that was administered was the patient's 2nd dose of DTaP and 2nd dose of IPV. The reporter consented to follow-up via email. The patient received 2nd dose of DTaP and IPV as Kinrix at inappropriate age, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 25.04.2023
- Impfdatum
- 24.04.2023
- Beginn
- 24.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Exposure via skin contact
Underdose
Symptomtext
While administering Proquad, patient moved and half the dose was wasted outside of patients arm. Patient only received half of the Proquad dose. Provider was aware and patient scheduled to come back to receive full dose of Proquad per provider discretion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure via skin contact
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 24.04.2023
- Impfdatum
- 24.03.2023
- Beginn
- 24.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
15 month old got Kinrix; Patient received Kinrix as their 3rd dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. Previously administered products included Pentacel (dose received on 22th April 2022) and Vaxelis (dose received on 23rd February 2023). On 24-MAR-2023, the patient received Kinrix. On 24-MAR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 15 month old got Kinrix) and inappropriate schedule of vaccine administered (Verbatim: Patient received Kinrix as their 3rd dose). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date 14-APR-2023 The reporter reported that the 15 months old patient received Kinrix vaccine due for DTaP and IPV as their third dose. The reporter did consent to follow up. The patient received Kinirix who was younger than the indicated age which led to inappropriate age at vaccine administration. The patient received Kinirix as a third dose of DTaP and IPV series which led to inappropriate schedule of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 24.04.2023
- Impfdatum
- 18.04.2023
- Beginn
- 19.04.2023
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Peripheral swelling
Symptomtext
Left arm redness and swelling noticed the day after vaccines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Growing pains (legs)
- Vorgeschichte
- none
- Andere Medikamente
- None
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 0,9
- Geschlecht
- M
- Eingang
- 24.04.2023
- Impfdatum
- 22.04.2023
- Beginn
- 22.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Symptomtext
no adverse event or symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 8,0
- Geschlecht
- M
- Eingang
- 21.04.2023
- Impfdatum
- 11.04.2023
- Beginn
- 11.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
an 8 year old patient received Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-year-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On 11-APR-2023, the patient received Kinrix. On 11-APR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: an 8 year old patient received Kinrix). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-APR-2023 The reporter declined to provide patient's initials. The reporter stated that 8 years old patient received Kinrix. The Vaccine administration facility was the same as Primary Reporter. The reporter consented to follow up via postal. The reporter stated that 8 years old patient received Kinrix, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 13.04.2023
- Impfdatum
- 10.04.2023
- Beginn
- 11.04.2023
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Skin warm
Symptomtext
Erythema and warmness to Right thigh, vesicle present; pt. referred to PCP. Proper hand hygiene, PPE (gloves), and alcohol wipe cleansed injection site prior to administration. Parent applied icepack to site. Pediatric Benadryl recommended. Referred to PCP for antibiotic if appropriate. PCP recommends oral Benadryl and wants to see patient if no improvement.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 12.04.2023
- Impfdatum
- 27.02.2023
- Beginn
- 27.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
THERE WERE NO ADVERSE EVENTS, GAVE VACCINE AT AGE 7 YRS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- ADHD
- Andere Medikamente
- QUILICHEW ER 20MG DEXOMETHAPHENIDATE ER 5MG
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 10.04.2023
- Impfdatum
- 28.03.2023
- Beginn
- 28.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
2 YO received Kinrix; Kinrix dose was this patient's fourth DTaP dose and third IPV dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-year-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. Previously administered products included DTap (last DTap dose 1 year ago) and IPV (IPV dose was 2 years ago). On 28-MAR-2023, the patient received Kinrix. On 28-MAR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 2 YO received Kinrix) and inappropriate schedule of vaccine administered (Verbatim: Kinrix dose was this patient's fourth DTaP dose and third IPV dose). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-MAR-2023 The Vaccine Administration Facility was the same as Primary Reporter. The reporter gave permission for follow-up, though did not wish to provide last name and did not have an email address to provide. The reporter consented to follow up. The patient received a dose of Kinrix as fourth DTaP dose and third IPV dose at inappropriate age, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 10.04.2023
- Impfdatum
- 20.12.2022
- Beginn
- 20.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Kinrix given to a 1-year-old; Kinrix given instead of Infanrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On 20-DEC-2022, the patient received Kinrix. On 20-DEC-2022, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix given to a 1-year-old) and wrong vaccine administered (Verbatim: Kinrix given instead of Infanrix). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 16-MAR-2023 The licensed vocational nurse (LVN) reported administration of Kinrix vaccine to a 1 year 3 month old patient instead of Infanrix. No adverse reaction noted with patient. The reporter consented to follow up. The patient received Kinrix vaccine instead of Infanrix at inappropriate age, which led to inappropriate age at vaccine administration and wrong vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 01.04.2023
- Impfdatum
- 06.03.2023
- Beginn
- 06.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
2 year old was administered Kinrix; Kinrix dose instead of Pentacel; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-year-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On 06-MAR-2023, the patient received Kinrix. On 06-MAR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 2 year old was administered Kinrix) and wrong vaccine administered (Verbatim: Kinrix dose instead of Pentacel). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-MAR-2023 The licensed practical nurse (LPN) called to enquire, regarding any information on any harm to the patient. The reporter asked would the patient need another DTap or how to proceed. The LPN reported a 2 year old patient was inadvertently administered a Kinrix dose instead of Pentacel, at an alternate office listed on HCP account. The reporter consented to follow up. The patient was inadvertently administered a Kinrix dose instead of Pentacel at inappropriate age, which led to inappropriate age at vaccine administration and wrong vaccine administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 31.03.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
two years and 9 months old received Kinrix; Got Kinrix as 3rd dose of Dtap series; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 33-month-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14-APR-2024) for prophylaxis. On an unknown date, the patient received Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: two years and 9 months old received Kinrix) and inappropriate schedule of vaccine administered (Verbatim: Got Kinrix as 3rd dose of Dtap series). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-MAR-2023 A nurse reported that a two years and 9 months old patient received her third dose of Dtap series vaccination with a Kinrix dose, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 30.03.2023
- Impfdatum
- 01.03.2023
- Beginn
- 29.03.2023
- Tage bis Beginn
- 28,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Kinrix dose was given by accident, should have been pediarix, pt family informed, baby is doing well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 24.03.2023
- Impfdatum
- 20.03.2023
- Beginn
- 20.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Poor quality product administered
Product storage error
Symptomtext
Kinrix vaccine was involved in a temperature excursion, not deemed viable by manufacturer and vaccine will need to be repeated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Poor quality product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 0,4
- Geschlecht
- M
- Eingang
- 10.03.2023
- Impfdatum
- 20.02.2023
- Beginn
- 20.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
Kinrix given to a 5-month-old; Kinrix was 2nd dose of dtap and ipv; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 5-month-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14th April 2024) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 20th February 2023, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 20th February 2023, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 1-Mar-2023 Reporter's Comments: A clinic manager reported that a 5-month-old male patient received a dose of Kinrix on 20th February 2023. No symptoms reported. Health care professional (HCP) reported, to the 2nd line agent, that Kinrix was patients 2nd dose of dtap and ipv and HCP was not sure what the intention was to give or timing of previous doses. The reporter consented to follow up via email. Additional Supportive Information: the patient received Kinrix as 2nd dose of Dtap and IPV vaccine, which led to inappropriate age at vaccine administration, inappropriate schedule of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,8
- Geschlecht
- M
- Eingang
- 09.03.2023
- Impfdatum
- 07.03.2023
- Beginn
- 07.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 06.03.2023
- Impfdatum
- 06.03.2023
- Beginn
- 06.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Gave Pfizer monovalent 5y-11y vaccine to this 4 year old. Tolerated well, monitored for 15 minutes after dose given
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- children multivitamin
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 04.03.2023
- Impfdatum
- 18.01.2023
- Beginn
- 18.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Inappropriate schedule of product administration
Symptomtext
18JAN dose was 3rd of DTAP and IPV, 23FEB dose was the 4th of each; received an extra dose; 18JAN dose was 3rd of DTAP and IPV, 23FEB dose was the 4th of each; This case was reported by a nurse via call center representative and described the occurrence of inappropriate schedule of vaccine administered in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number g9n2m, expiry date 14th April 2024) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-IPV (Kinrix) (batch number g9n2m, expiry date 14th April 2024) for prophylaxis and dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 23rd February 2023, the patient received the 2nd dose of Kinrix (intramuscular) and Kinrix Pre-Filled Syringe Device. On 18th January 2023, the patient received the 1st dose of Kinrix (intramuscular) and Kinrix Pre-Filled Syringe Device. On 18th January 2023, not applicable after receiving Kinrix and Kinrix Pre-Filled Syringe Device and unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate schedule of vaccine administered. On 23rd February 2023, the patient experienced inappropriate schedule of vaccine administered and extra dose administered. On an unknown date, the outcome of the inappropriate schedule of vaccine administered, inappropriate schedule of vaccine administered and extra dose administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 23-Feb-2023 and 27-Feb-2023. Reporter's Comment: Reporter stated that patient accidently received an extra dose of Kinrix. Patient stated that 1st dose of Kinrix was 3rd dose of DTP and IPV and 2nd dose of Kinrix was 4th dose of DTP and IPV. The reporter consent to follow up. Additional Supportive Information: Patient received an extra second dose of kinrix than the recommended schedule, which led to extra dose administered. Patient received 1st dose of Kinrix as 3rd dose of DTP and IPV and 2nd dose of Kinrix as 4th dose of DTP and IPV than the recommended schedule, which led to inappropriate schedule of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 04.03.2023
- Impfdatum
- 18.01.2023
- Beginn
- 18.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Inappropriate schedule of product administration
Symptomtext
18JAN dose was 3rd of DTAP and IPV, 23FEB dose was the 4th of each; received an extra dose; 18JAN dose was 3rd of DTAP and IPV, 23FEB dose was the 4th of each; This case was reported by a nurse via call center representative and described the occurrence of inappropriate schedule of vaccine administered in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number g9n2m, expiry date 14th April 2024) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-IPV (Kinrix) (batch number g9n2m, expiry date 14th April 2024) for prophylaxis and dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 23rd February 2023, the patient received the 2nd dose of Kinrix (intramuscular) and Kinrix Pre-Filled Syringe Device. On 18th January 2023, the patient received the 1st dose of Kinrix (intramuscular) and Kinrix Pre-Filled Syringe Device. On 18th January 2023, not applicable after receiving Kinrix and Kinrix Pre-Filled Syringe Device and unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate schedule of vaccine administered. On 23rd February 2023, the patient experienced inappropriate schedule of vaccine administered and extra dose administered. On an unknown date, the outcome of the inappropriate schedule of vaccine administered, inappropriate schedule of vaccine administered and extra dose administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 23-Feb-2023 and 27-Feb-2023. Reporter's Comment: Reporter stated that patient accidently received an extra dose of Kinrix. Patient stated that 1st dose of Kinrix was 3rd dose of DTP and IPV and 2nd dose of Kinrix was 4th dose of DTP and IPV. The reporter consent to follow up. Additional Supportive Information: Patient received an extra second dose of kinrix than the recommended schedule, which led to extra dose administered. Patient received 1st dose of Kinrix as 3rd dose of DTP and IPV and 2nd dose of Kinrix as 4th dose of DTP and IPV than the recommended schedule, which led to inappropriate schedule of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 27.02.2023
- Impfdatum
- 25.01.2023
- Beginn
- 25.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
Given Kinrix and should have received TDAP and Polio seperate
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 8,0
- Geschlecht
- F
- Eingang
- 24.02.2023
- Impfdatum
- 31.01.2023
- Beginn
- 31.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Kinrix administered outside of manufacturer recommended age range
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 21.02.2023
- Impfdatum
- 15.02.2023
- Beginn
- 01.02.2023
- Tage bis Beginn
- -
- Dosis
- N/A
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
No sign of adverse event, vaccination given too early
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 21.02.2023
- Impfdatum
- 07.02.2023
- Beginn
- 07.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Decreased appetite
Hypersomnia
Infant irritability
Symptomtext
Patient had some fussiness, sleeping more and decreased appetite, 24 hours after vaccine. Spoke with mother to see how patient was doing. Mother stated he was doing better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Decreased appetite
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- upper respiratory infection in January 2022
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 0,8
- Geschlecht
- F
- Eingang
- 14.02.2023
- Impfdatum
- 01.02.2023
- Beginn
- 01.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Vaccination error
Symptomtext
Patient did NOT have adverse/allergic reaction to immunization given. The CDC recommends the following "This vaccine should not be administered to children aged <4 years or >7 years; however, if DTaP-IPV (Kinrix) is inadvertently administered for an earlier dose of the DTaP and/or IPV series, the dose should be counted as valid and does not need to be repeated provided minimum interval requirements have been met". Parent/Guardian contacted about immunization error as well as CDC recommendations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- fluoride 0.5 mg (1.1 mg sodium fluoride)/mL oral drops
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,6
- Geschlecht
- M
- Eingang
- 14.02.2023
- Impfdatum
- 13.01.2023
- Beginn
- 13.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient was given vaccine not approved for age
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 09.02.2023
- Impfdatum
- 30.01.2023
- Beginn
- 30.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Kinrix administered to a 4 months-old; Kinrix administered instead of Pentacel; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14th April 2024) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 30th January 2023, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 30th January 2023, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 31-Jan-2023 Reporter's comment: The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. Additional supportive information: The patient received a dose of Kinrix instead of Pentacel at inappropriate age, which led to inappropriate age at vaccine administration and wrong vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 1,8
- Geschlecht
- F
- Eingang
- 08.02.2023
- Impfdatum
- 08.02.2023
- Beginn
- 01.02.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Administered Kinrix vaccine to child aged 1 year 9 months, later staff entering paperwork informed nurse that I had admnistered a vaccine to child under recommended age,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- UNK
- Vorgeschichte
- UNK
- Andere Medikamente
- UNK
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 02.02.2023
- Impfdatum
- 01.02.2023
- Beginn
- 02.02.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
Pt. was administered Kinrix instead of Pediarix.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- plagiocephaly
- Vorgeschichte
- plagiocephaly
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 20.01.2023
- Impfdatum
- 19.01.2023
- Beginn
- 20.01.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Patient was due for IPV and DTap so she was given Kinrix. Staff unaware at time that kinrix should not be given past the age of six. Patient didn't report any adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,9
- Geschlecht
- M
- Eingang
- 20.01.2023
- Impfdatum
- 20.01.2023
- Beginn
- 20.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
Patient was due for a Dtap and IPV, we do not have IPV in the office. I asked Dr if I could give Kinrix and he said yes. I gave it with my providers permission. The patient is fine, has not experienced any adverse outcomes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 19.01.2023
- Impfdatum
- 12.01.2023
- Beginn
- 12.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 7+
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
No adverse event
Symptomtext
Patient was given a 7th dose of DTaP by age 4yr. Patient had history of 2 invalid doses previously. No adverse outcomes that we are aware of at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 1,1
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 07.01.2023
- Beginn
- 09.01.2023
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
M.A wrongly gave Kinrix vaccine to a 1 year old
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 04.01.2023
- Impfdatum
- 06.12.2022
- Beginn
- 06.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs; temperature excursion; This spontaneous report was received from a registered nurse and refers to a 4-year-old female patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 06-DEC-2022, the patient was vaccinated with improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA) (M-M-R II) subcutaneous injection, lot #U039549, expiration date: 14-DEC-2023, administered subcutaneously for prophylaxis (dose and strength were not provided); and varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #W018825, expiration date: 14-JUN-2024, administered subcutaneously for prophylaxis (dose and strength were not provided); diphtheria vaccine toxoid, pertussis vaccine acellular 1-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (DTaP-IPV), lot #G9N2M, expiration date: 14-APR-2024, administered intramuscularly (dose, strength, formulation, and indication were not provided) (product storage error). On an unknown date, before the administration, the vaccines underwent temperature excursion for unknown period of time. There was no adverse event reported. The reporter considered temperature excursion to be not related to suspect vaccines.; Sender's Comments: US-009507513-2212USA003061: US-009507513-2212USA007828: US-009507513-2212USA007829: US-009507513-2212USA007830: US-009507513-2212USA007831: US-009507513-2212USA007832: US-009507513-2212USA007833: US-009507513-2212USA007834: US-009507513-2212USA007835: US-009507513-2212USA007836: US-009507513-2212USA007838:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 03.01.2023
- Impfdatum
- 19.12.2022
- Beginn
- 19.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Patient received COVID19 Moderna Bivalent vaccine as first dose of primary series.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 7,0
- Geschlecht
- F
- Eingang
- 27.12.2022
- Impfdatum
- 14.12.2022
- Beginn
- 14.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
we are not aware of any adverse reactions or symptoms
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- cherries erythromycin
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 7,0
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 17.11.2022
- Beginn
- 17.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
7 year old was administered Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old female patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14th April 2024) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 17th November 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 17th November 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 9-Dec-2022 Reporter's comment: The reporter knew that this was outside the recommended age range. The reporter consented to follow-up. Additional supportive information: The patient received a dose of Kinrix in error at inappropriate age, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 10,0
- Geschlecht
- M
- Eingang
- 20.12.2022
- Impfdatum
- 20.12.2022
- Beginn
- 20.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 6
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Circumstance or information capable of leading to medication error
Extra dose administered
Wrong product administered
Symptomtext
2 siblings have well child check appts (10 yrs and 4 yrs), both were very nervous and moving around during vaccination time. Mother of child did really good job by holding them, but still both were really afraid and moving a lot. I grabbed the wrong tray of vaccines, I had 2, but still grabbed the wrong one. Mother of child saw and said, "I think you bragged the wrong tray" "I think that one is for my 4 yrs child." Once I notice I stopped and explained MOC about the incident. Explained technically patient got extra vaccines today and it wont hurt patient. Explained will speak with Dr about this incident. MOC did not argue, states agree and continue to vaccine patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Circumstance or information capable of leading to medication error
- Hospital-Tage
- -
- Labordaten
- per Dr NO need for any testing, states agree patient got extra doses today and as long as mother of child is OK and agree. Mother of child OK and did not want to take this case further, MOC states understanding what happened and Ok with it, agree.
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- NO
- Andere Medikamente
- NO
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 13.12.2022
- Impfdatum
- 13.12.2022
- Beginn
- 13.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
Provider ordered Dtap, I gave kinrix (Dtap, IPV) instead of Dtap. Patient had last Dtap on 12/20/2019 Last Polio 12/20/2019. Spoke with on call nurse with vaccination information, she stated patient will need Polio at age 4.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 09.12.2022
- Impfdatum
- 09.12.2022
- Beginn
- 09.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Patient was given the wrong vaccine. Patient was told of this, now are waiting for Provider instruction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 09.12.2022
- Impfdatum
- 08.12.2022
- Beginn
- 08.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
4 month old patient given Kinrex vaccine on mistake. Kinrex vaccine not approved for this age group. No adverse reactions were observed or reported from the family.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Bronchitis
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 09.12.2022
- Impfdatum
- 08.12.2022
- Beginn
- 08.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Patient was given Kinrex vaccine and was not the correct/eligible age for that vaccine. No treatment required. No adverse reactions expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 07.12.2022
- Impfdatum
- 16.11.2022
- Beginn
- 23.11.2022
- Tage bis Beginn
- 7,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Wrong product administered
Symptomtext
Patient was given live vaccines while taking Ilaris, which should not be given/taken at the same time. Patient/guardian is not reporting any adverse effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Ilaris, albuterol
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 28.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Kinrix administered instead of Infanrix; Kinrix administred to a 18-month-old; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 1-year-old male patient who received DTPa-IPV (Kinrix) (batch number G9N2M, expiry date 14th April 2024) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 18th November 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 18th November 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 18-Nov-2022 Reporter's comment: The reporter did not consent to follow-up. Additional supportive information: The patient received Kinrix dose instead of Infanrix vaccine at inappropriate age, which led to wrong vaccine administered and inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 23.11.2022
- Impfdatum
- 21.11.2022
- Beginn
- 21.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Received early dose of Kinrix & proquad
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 1,5
- Geschlecht
- M
- Eingang
- 18.11.2022
- Impfdatum
- 14.11.2022
- Beginn
- 14.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
I incorrectly administer Kinrix to my pt who was 1 year and 6 months old. I grabbed the Kinrix instead of the Infanrix.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 0,4
- Geschlecht
- F
- Eingang
- 10.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Symptomtext
5 month old patient was administer Kinrix, which is approved for ages 4-6 years. Patient/patient's parent has not reported any adverse reactions from the shot or other health concerns.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 2,8
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 07.10.2022
- Beginn
- 07.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 27.10.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
Patient presented for well child exam. School advised mom that child needed vaccines. Per system patient was due for Kinrix, Proquad and influenza. These vaccinations were administered at visit. Upon charting of vaccinations, nurse realized patient was given Kinrix and Proquad in August of 2021. The vaccinations did not cross over into system. Patient was given extra set of vaccines. No adverse reactions noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- obesity, dental caries
- Andere Medikamente
- certizine, fluticasone
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 27.10.2022
- Impfdatum
- 26.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
During charting of above administered vaccines, noted patient had received 4 year well vaccines two days prior on 10/24 (mom had marked "no" to vaccines in prior 4 weeks on screening form, and printed vaccine records available at time of visit did not list vaccines from 10/24. Vaccines received in duplicate: Fluzone, Lot UJ879AB, given in Left thigh on 10/24/22 MMRV, Lot W020548, given in Right thigh on 10/24/22 Kinrix, Lot 2kl4k, given in Left thigh on 10/24/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- zyrtec
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 10.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong patient
Wrong product administered
Symptomtext
Child present in office to receive flu vaccine only - sibling also being seen at same office encounter for 4 year well child visit. Child apprehensive about receiving vaccinations and mother requested that child not be advised of vaccines until last possible moment to avoid causing additional anxiety. Nurse attempted to verify child as the child receiving four total vaccines and then administered vaccines intended for 4 year old sibling to older child swiftly and then subsequently realized that vaccines injected in to incorrect child. Mother advised of error and that report to be created. Instructed to contact office immediately if child developed fever, redness or swelling at injection site, tenderness or worsening pain. Mother appropriately concerned and expressed understanding.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong patient
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -